CIK: 0001595851 · Show all filings
Period: Q1 2020 (← Previous) (Next →)
Filing Date: May 15, 2020
Total Value: $377M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| XBI | SPDR SER TR | 737,500 | $57.11M | 15.1% | $77.44 | — | — | Put | 78464A870 |
| SPY | SPDR S&P 500 ETF TR | 146,700 | $37.81M | 10.0% | $257.75 | — | — | Put | 78462F103 |
| QQQ | INVESCO QQQ TR | 174,200 | $33.17M | 8.8% | $190.40 | — | — | Put | 46090E103 |
| XLV | SELECT SECTOR SPDR TR | 244,700 | $21.68M | 5.7% | $88.58 | — | — | Call | 81369Y209 |
| — | CONSTELLATION PHARMCETICLS I | 650,000 | $20.43M | 5.4% | $31.43 | $45.31 | — | COM | 210373106 |
| ASND | ASCENDIS PHARMA A S | 150,000 | $16.89M | 4.5% | $112.61 | $106.36 | — | SPONSORED ADR | 04351P101 |
| — | IMMUNOMEDICS INC | 1,050,000 | $14.15M | 3.8% | $13.48 | $11.44 | — | COM | 452907108 |
| — | ADVERUM BIOTECHNOLOGIES INC | 1,305,500 | $12.76M | 3.4% | $9.77 | $5.88 | — | COM | 00773U108 |
| AXSM | AXSOME THERAPEUTICS INC | 215,000 | $12.65M | 3.4% | $58.83 * | $20.68 | +294.0% | COM | 05464T104 |
| — | MERSANA THERAPEUTICS INC | 2,000,000 | $11.66M | 3.1% | $5.83 | $5.79 | — | COM | 59045L106 |
| IMVT | IMMUNOVANT INC | 710,000 | $11.05M | 2.9% | $15.56 * | $11.17 | +34.7% | COM | 45258J102 |
| — | MOMENTA PHARMACEUTICALS INC | 400,000 | $10.88M | 2.9% | $27.20 | $13.20 | — | COM | 60877T100 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 350,000 | $10.48M | 2.8% | $29.93 * | $19.38 | +36.7% | COM | 462260100 |
| RCKT | ROCKET PHARMACEUTICALS INC | 650,000 | $9.068M | 2.4% | $13.95 * | $15.79 | +25.4% | COM | 77313F106 |
| — | MIRATI THERAPEUTICS INC | 115,000 | $8.84M | 2.3% | $76.87 | $71.66 | — | COM | 60468T105 |
| — | REATA PHARMACEUTICALS INC | 50,000 | $7.217M | 1.9% | $144.34 | $121.68 | — | CL A | 75615P103 |
| AUPH | AURINIA PHARMACEUTICALS INC | 400,000 | $5.804M | 1.5% | $14.51 * | $9.21 | +91.5% | COM | 05156V102 |
| FATE | FATE THERAPEUTICS INC | 225,000 | $4.997M | 1.3% | $22.21 * | $19.17 | +31.9% | COM | 31189P102 |
| — | MYOVANT SCIENCES LTD | 585,000 | $4.417M | 1.2% | $7.55 | $13.68 | — | COM | G637AM102 |
| — | SELECTA BIOSCIENCES INC | 1,725,000 | $4.157M | 1.1% | $2.41 | $2.39 | — | COM | 816212104 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 2,000,000 | $4M | 1.1% | $2.00 * | $4.34 | -36.5% | COM | 09058V103 |
| — | VERASTEM INC | 1,500,000 | $3.96M | 1.1% | $2.64 | $2.64 | — | COM | 92337C104 |
| — | ZOGENIX INC | 150,000 | $3.71M | 1.0% | $24.73 | $24.73 | — | COM NEW | 98978L204 |
| XENE | XENON PHARMACEUTICALS INC | 325,000 | $3.686M | 1.0% | $11.34 * | $14.24 | 0.0% | COM | 98420N105 |
| — | TRILLIUM THERAPEUTICS INC | 825,000 | $3.333M | 0.9% | $4.04 | $4.04 | — | COM NEW | 89620X506 |
| ARVN | ARVINAS INC | 80,000 | $3.224M | 0.9% | $40.30 * | $19.57 | +139.0% | COM | 04335A105 |
| — | HOMOLOGY MEDICINES INC | 200,000 | $3.108M | 0.8% | $15.54 | $15.54 | — | COM | 438083107 |
| — | IVERIC BIO INC | 828,459 | $2.85M | 0.8% | $3.44 | $8.09 | — | COM | 46583P102 |
| — | AVADEL PHARMACEUTICALS PLC | 350,000 | $2.779M | 0.7% | $7.94 | $7.94 | — | SPONSORED ADR | 05337M104 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 250,000 | $2.743M | 0.7% | $10.97 * | $9.38 | 0.0% | COM | 87164F105 |
| KALV | KALVISTA PHARMACEUTICALS INC | 350,000 | $2.678M | 0.7% | $7.65 * | $15.74 | -14.3% | COM | 483497103 |
| — | SATSUMA PHARMACEUTICALS INC | 115,000 | $2.475M | 0.7% | $21.52 | $21.52 | — | COM | 80405P107 |
| CHRS | COHERUS BIOSCIENCES INC | 150,000 | $2.433M | 0.6% | $16.22 * | $18.44 | +0.2% | COM | 19249H103 |
| FXE | INVESCO CURRENCYSHARES EURO | 20,830 | $2.173M | 0.6% | $104.32 | $104.32 | — | EURO SHS | 46138K103 |
| TGTX | TG THERAPEUTICS INC | 200,000 | $1.968M | 0.5% | $9.84 * | $11.05 | +14.3% | COM | 88322Q108 |
| VRAYQ | VIEWRAY INC | 782,928 | $1.957M | 0.5% | $2.50 * | $5.75 | -50.7% | COM | 92672L107 |
| — | SAGE THERAPEUTICS INC | 65,000 | $1.867M | 0.5% | $28.72 | $28.72 | — | COM | 78667J108 |
| CUE | CUE BIOPHARMA INC | 125,000 | $1.774M | 0.5% | $14.19 * | $16.16 | 0.0% | COM | 22978P106 |
| — | KINIKSA PHARMACEUTICALS LTD | 112,695 | $1.745M | 0.5% | $15.48 | $11.06 | — | COM CL A | G5269C101 |
| — | PHASEBIO PHARMACEUTICALS INC | 497,074 | $1.645M | 0.4% | $3.31 | $5.85 | — | COM | 717224109 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 227,827 | $1.608M | 0.4% | $7.06 * | $9.61 | -22.1% | COM | 74366E102 |
| — | KADMON HLDGS INC | 350,000 | $1.467M | 0.4% | $4.19 | $3.79 | — | COM | 48283N106 |
| — | ORCHARD THERAPEUTICS PLC | 178,109 | $1.341M | 0.4% | $7.53 | $15.73 | — | ADS | 68570P101 |
| — | APPLIED GENETIC TECHNOL CORP | 372,806 | $1.223M | 0.3% | $3.28 | $3.28 | — | COM | 03820J100 |
| BIIB | BIOGEN INC | 3,250 | $1.028M | 0.3% | $316.31 * | $303.47 | 0.0% | COM | 09062X103 |
| — | AMARIN CORP PLC | 165,600 | $662K | 0.2% | $4.00 | — | — | Call | 023111206 |
| MIST | MILESTONE PHARMACEUTICALS IN | 208,733 | $384K | 0.1% | $1.84 * | $20.62 | -16.0% | COM | 59935V107 |